Jan. 21, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, today announced the appointment of Ms. Michal Ahuvia ...

On Friday, Microbot Medical Inc (MBOT) stock saw a modest uptick, ending the day at $2.03 which represents a slight increase of $0.12 or 6.28% from the prior close of $1.91. The stock opened at $2.02 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Mbot 3D belongs to MagicFirm, which was founded in 2009. It is the first 3D printing service provider in China. MagicFirm is committed to providing integrated solutions for architectural design, ...

H.C. Wainwright has recently reiterated Microbot Medical Inc (MBOT) stock to Buy rating, as announced on January 13, 2020, according to Finviz. Earlier, on December 24, 2019, H.C. Wainwright had ...

After hours: 7:59:20 pm GMT-5 ...

After hours: January 24 at 7:59:31 p.m. EST ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

(Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System. Microbot Medical Inc. (Nasdaq: MBOT) is currently trading at $1.7394, up 0.5994, gaining 52.82% on volume of over ...